OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

HTML

Year: 2005
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-04-1070
Authors: Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom, George Tkalcevic, Ann Marie Rossi, Penny E. Miller, Mark W. Tengowski, Faye Wang, Antonio Gualberto, Jean S. Beebe, James D. Moyer
Institution: Pfizer (United States)
Language: English

Topic: Growth Hormone and Insulin-like Growth Factors
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: IGF-1 receptor, insulin-like growth factor signaling, monoclonal antibodies, combination therapy, anticancer activity, receptor down-regulation, receptor autophosphorylation, pharmacokinetics, biomarker assays, doxorubicin, 5-fluorouracil, tamoxifen, cancer therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2121520362
FWCI: 17.49
Cites: 30
Cited by: 381
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms